This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 May;128(5):e26-e27.

doi: 10.1016/j.ophtha.2020.12.031. Epub 2021 Feb 5.

Reply

Affiliations

Affiliations

¹ Department of Ophthalmology, Duke University, Durham, North Carolina.
² IVERIC bio, Inc, New York, New York.
³ Retina Foundation of Southwest, Dallas, Texas.
⁴ Institut de la Màcula and Barcelona Macula Foundation, Barcelona, Spain.
⁵ Vitreoretinal Medical Group, Inc, Sacramento, California.
⁶ West Texas Retina Consultants, Abilene, Texas.
⁷ Colorado Retina, Denver, Colorado.
⁸ Center for Retina and Macular Disease, Winter Haven, Florida.
⁹ IVERIC bio, Inc, New York, New York. Electronic address: karesaei@yahoo.com.

PMID: 33551285
DOI: 10.1016/j.ophtha.2020.12.031

Comment

Reply

Glenn J Jaffe et al. Ophthalmology. 2021 May.

. 2021 May;128(5):e26-e27.

doi: 10.1016/j.ophtha.2020.12.031. Epub 2021 Feb 5.

Authors

Affiliations

¹ Department of Ophthalmology, Duke University, Durham, North Carolina.
² IVERIC bio, Inc, New York, New York.
³ Retina Foundation of Southwest, Dallas, Texas.
⁴ Institut de la Màcula and Barcelona Macula Foundation, Barcelona, Spain.
⁵ Vitreoretinal Medical Group, Inc, Sacramento, California.
⁶ West Texas Retina Consultants, Abilene, Texas.
⁷ Colorado Retina, Denver, Colorado.
⁸ Center for Retina and Macular Disease, Winter Haven, Florida.
⁹ IVERIC bio, Inc, New York, New York. Electronic address: karesaei@yahoo.com.

PMID: 33551285
DOI: 10.1016/j.ophtha.2020.12.031

No abstract available

PubMed Disclaimer

Comment on

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. Jaffe GJ, et al. Ophthalmology. 2021 Apr;128(4):576-586. doi: 10.1016/j.ophtha.2020.08.027. Epub 2020 Sep 1. Ophthalmology. 2021. PMID: 32882310 Clinical Trial.
Re: Jaffe et al.: C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial (Ophthalmology. 2021;128:576-586).
Keenan TDL. Keenan TDL. Ophthalmology. 2021 May;128(5):e25-e26. doi: 10.1016/j.ophtha.2020.12.030. Epub 2021 Feb 4. Ophthalmology. 2021. PMID: 33551286 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations